On April 3, 2017, updated results from the National Birth Defects Prevention Study (NBDPS) were released and published in the article "Maternal Antihypertensive Medication Use and Congenital Heart Defects" (Abstract only). This study found that there was a statistically significant association between β-blocker use in pregnant women and fetal … [Read more...]